| Financial Year |
March 31 2023 |
| Monetary Funds |
5,486,161,817.78 |
| Held-for-trading Financial Assets |
809,874.90 |
| Notes Receivable |
2,058,726,469.62 |
| Accounts Receivable |
5,317,933,765.74 |
| Advances to Suppliers |
582,335,559.37 |
| Other Receivables |
266,077,645.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
233,724.30 |
| Dividend Receivable |
-- |
| Inventories |
5,161,866,603.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
107,566.37 |
| Other Current Assets |
1,621,240,027.89 |
| Total Current Assets |
21,470,592,482.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,816,530.27 |
| Long-term Equity Investment |
775,572,757.95 |
| Investment Properties |
1,276,786,880.11 |
| Fixed Assetes |
13,182,137,430.13 |
| Under-construction Projects |
13,019,920,982.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,412,296,251.47 |
| R&D expenses |
-- |
| Goodwill |
275,070,621.59 |
| Long-Term Deferred and Prepaid Expenses |
392,825,136.19 |
| Deferred Income Tax Assets |
499,601,034.40 |
| Other Non-Current Assets |
2,536,048,019.56 |
| Sub-Total of Non-Current Assets |
35,715,853,563.09 |
| Total Assets |
57,186,446,045.36 |
| Short-Term Loans |
4,436,169,836.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,178,542,562.82 |
| Accounts Payable |
3,381,440,581.60 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
174,260,231.75 |
| Taxes Payable |
235,457,247.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,164,891,061.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,828,768,193.27 |
| Other Current Liabilities |
1,286,631,221.63 |
| Sub-Total of Current Liabilities |
19,134,793,530.60 |
| Long-term Loans |
16,309,207,196.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
72,561.10 |
| Deferred Income Tax Liabilities |
239,630,156.82 |
| Other Non-Current Liabilities |
2,127,141,229.54 |
| Sub-Total of Non-Current Liabilities |
19,472,798,016.97 |
| Total Liabilities |
38,607,591,547.57 |
| Paid-In Capital(Or Share Stock) |
2,657,197,236.00 |
| Capital Surplus |
3,360,085,517.11 |
| Surplus Reserve |
1,287,756,323.17 |
| LESS:Treasury Stock |
459,661,911.50 |
| Undistributed Profits |
9,985,632,686.72 |
| Minority Stockholder's Interest |
1,751,199,923.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,827,654,573.81 |
| Owner's Equity（Stockholder's Equity） |
18,578,854,497.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
57,186,446,045.36 |
